Protagonist Therapeutics, Inc. (PTGX)
92.52
-2.31
(-2.44%)
USD |
NASDAQ |
Mar 05, 10:11
Protagonist Therapeutics Research and Development Expense (Annual) : 159.29M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| ADMA Biologics, Inc. | 4.762M |
| Glaukos Corp. | 150.61M |
| Krystal Biotech, Inc. | 52.32M |
| Olema Pharmaceuticals, Inc. | 124.52M |